|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product | |||||
| Service | |||||
| Total revenue | |||||
| Cost of revenue | |||||
| Product | |||||
| Service | |||||
| Total cost of revenue | |||||
| Gross loss | |||||
| Operating expenses | |||||
| Research and development | |||||
| Selling and marketing | |||||
| General and administrative | |||||
| Total Operating expenses | |||||
| Loss from operations | |||||
| Interest expense, net | |||||
| Interest expense | |||||
| Interest income | |||||
| Gain from disposal of investment in unconsolidated subsidiary | |||||
| Gain on sale of Atlas | |||||
| Loss from change in fair value of warrant liability | |||||
| Loss on extinguishment of debt | |||||
| Other expense, net | |||||
| Other income, net | |||||
| Income (loss) from unconsolidated subsidiary | |||||
| Loss before income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Other comprehensive income (loss): | |||||
| Foreign currency translation adjustments | |||||
| Comprehensive loss | |||||
| Net loss per share | |||||
| Basic | |||||
| Diluted | |||||
| Weighted-average common shares outstanding: | |||||
| Basic weighted-average number of common shares outstanding | |||||
| Diluted weighted-average number of common shares outstanding |
Loading...